Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
FTSE 100
8,213.49
+41.34
(+0.51%)
FTSE 250
20,164.54
+112.21
(+0.56%)
AIM
771.53
+3.42
(+0.45%)
GBP/EUR
1.1652
-0.0031
(-0.26%)
GBP/USD
1.2546
+0.0013
(+0.11%)
Bitcoin GBP
50,380.32
+2,916.78
(+6.15%)
MONEY
Best savings accounts that offer above inflation rates
Where to find a top-rated deal that works for you
Aclaris Therapeutics, Inc. (ACRS)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.3600
+0.0500
(+3.82%)
At close: 04:00PM EDT
1.3800
+0.02
(+1.47%)
After hours:
07:56PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
31,249
31,249
29,752
6,761
6,482
Cost of revenue
18,081
18,081
11,960
4,713
5,133
Gross profit
13,168
13,168
17,792
2,048
1,349
Operating expenses
Research development
98,384
98,384
77,813
43,813
29,338
Selling general and administrative
31,098
31,098
25,133
23,619
20,530
Total operating expenses
129,482
129,482
102,946
67,432
49,868
Operating income or loss
-116,314
-116,314
-85,154
-65,384
-48,519
Total other income/expenses net
27,466
27,466
-1,754
-25,481
-2,817
Income before tax
-88,848
-88,848
-86,908
-90,865
-51,336
Income tax expense
-367
-367
0
0
-182
Income from continuing operations
-88,481
-88,481
-86,908
-90,865
-51,154
Net income
-88,481
-88,481
-86,908
-90,865
-51,015
Net income available to common shareholders
-88,481
-88,481
-86,908
-90,865
-51,015
Basic EPS
-1.66
-
-1.33
-1.60
-1.20
Diluted EPS
-1.66
-
-1.33
-1.60
-1.20
Basic average shares
68,765
-
65,214
56,731
42,539
Diluted average shares
68,765
-
65,214
56,731
42,539
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.